These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 16018986)

  • 1. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum.
    Martinez D; Gil R; Slifstein M; Hwang DR; Huang Y; Perez A; Kegeles L; Talbot P; Evans S; Krystal J; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2005 Nov; 58(10):779-86. PubMed ID: 16018986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.
    Martinez D; Slifstein M; Broft A; Mawlawi O; Hwang DR; Huang Y; Cooper T; Kegeles L; Zarahn E; Abi-Dargham A; Haber SN; Laruelle M
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):285-300. PubMed ID: 12621304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.
    Martinez D; Narendran R; Foltin RW; Slifstein M; Hwang DR; Broft A; Huang Y; Cooper TB; Fischman MW; Kleber HD; Laruelle M
    Am J Psychiatry; 2007 Apr; 164(4):622-9. PubMed ID: 17403976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study.
    Urban NB; Slifstein M; Thompson JL; Xu X; Girgis RR; Raheja S; Haney M; Abi-Dargham A
    Biol Psychiatry; 2012 Apr; 71(8):677-83. PubMed ID: 22290115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
    Kegeles LS; Abi-Dargham A; Frankle WG; Gil R; Cooper TB; Slifstein M; Hwang DR; Huang Y; Haber SN; Laruelle M
    Arch Gen Psychiatry; 2010 Mar; 67(3):231-9. PubMed ID: 20194823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
    van Berckel BN; Kegeles LS; Waterhouse R; Guo N; Hwang DR; Huang Y; Narendran R; Van Heertum R; Laruelle M
    Neuropsychopharmacology; 2006 May; 31(5):967-77. PubMed ID: 16177807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion.
    Martinez D; Greene K; Broft A; Kumar D; Liu F; Narendran R; Slifstein M; Van Heertum R; Kleber HD
    Am J Psychiatry; 2009 Oct; 166(10):1170-7. PubMed ID: 19723785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
    Abi-Jaoude E; Segura B; Obeso I; Cho SS; Houle S; Lang AE; Rusjan P; Sandor P; Strafella AP
    Hum Brain Mapp; 2015 Jul; 36(7):2592-601. PubMed ID: 25788222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.
    Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
    J Clin Psychopharmacol; 2011 Aug; 31(4):507-11. PubMed ID: 21694619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.
    Schneier FR; Abi-Dargham A; Martinez D; Slifstein M; Hwang DR; Liebowitz MR; Laruelle M
    Depress Anxiety; 2009; 26(5):411-8. PubMed ID: 19180583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior.
    Martinez D; Broft A; Foltin RW; Slifstein M; Hwang DR; Huang Y; Perez A; Frankle WG; Cooper T; Kleber HD; Fischman MW; Laruelle M
    Neuropsychopharmacology; 2004 Jun; 29(6):1190-202. PubMed ID: 15010698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
    Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study.
    Spreckelmeyer KN; Paulzen M; Raptis M; Baltus T; Schaffrath S; Van Waesberghe J; Zalewski MM; Rösch F; Vernaleken I; Schäfer WM; Gründer G
    Biol Psychiatry; 2011 Oct; 70(8):770-776. PubMed ID: 21802658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine release and family history of alcoholism.
    Munro CA; McCaul ME; Oswald LM; Wong DF; Zhou Y; Brasic J; Kuwabara H; Kumar A; Alexander M; Ye W; Wand GS
    Alcohol Clin Exp Res; 2006 Jul; 30(7):1143-51. PubMed ID: 16792561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum.
    Drevets WC; Price JC; Kupfer DJ; Kinahan PE; Lopresti B; Holt D; Mathis C
    Neuropsychopharmacology; 1999 Dec; 21(6):694-709. PubMed ID: 10633475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.